Accéder au contenu
Merck

Syncytia Induction by Clinical Isolates of Human Respiratory Syncytial Virus A.

Intervirology (2017-09-05)
Talita Bianca Gagliardi, Miriã Ferreira Criado, José Luiz Proença-Módena, Ariane Mirela Saranzo, Marisa Akiko Iwamoto, Flávia Escremim de Paula, Ricardo Souza Cardoso, Luana Sela Delcaro, Maria Lúcia Silva, Ataide Ademir Câmara, Eurico Arruda
RÉSUMÉ

Syncytia formation is the hallmark of the cytopathic effect caused by human respiratory syncytial virus (HRSV), which is the most important viral respiratory pathogen in children. This article reports methodological improvements in primary HRSV isolation and the importance of syncytia formation and mRNA levels of F protein for the progeny yield, using clinical isolates of HRSV. The A and B strains of HRSV were isolated in HEp-2 cell cultures from fresh and frozen nasopharyngeal aspirates. The formation of syncytia was evaluated using 2 different assays. Levels of F protein mRNA were quantified by real-time PCR while HRSV progeny titration was done by plaque assay. HRSV was primarily isolated from 238 of 312 (90.7%) samples, and 13 of these (12 HRSV-A and 1 HRSV-B) were continuously passaged in vitro. The quantity and size of syncytia formed by 6 pure HRSV-A clinical isolates were different, as were the levels of F protein mRNA. There is a direct correlation of quantities of syncytia and inoculum size, but not with mRNA levels of HRSV-A F protein. Importantly, levels of F protein mRNA were directly related to progeny production.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anti-RSV Antibody, blend, clones 133-1H, 131-2G, and 130-12H, ascites fluid, Chemicon®, from mouse